Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bimatoprost in pediatric glaucoma
NCT01426113Phase 3Terminated
- Sponsor
- Allergan
- Start
- Sep 2011
- Primary completion
- Oct 2014
- Modality
- Orthosteric Ligands
- Countries
- 7
01
Overview
A Phase 3 trial of bimatoprost in Primary Congenital Glaucoma (PCG), Glaucoma, sponsored by Allergan. Started Sep 2011; status: terminated.
02
Drugs
bimatoprost
03
Conditions
Primary Congenital Glaucoma (PCG)Glaucoma
Beyond the preview
Go deeper on NCT01426113.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01426113.